You are here: Industry Insights > US

News List

Bipartisan bill revealed to lower drug prices in US europeanpharmaceuticalreview
July 25, 2019
The Senate Finance Committee has unveiled its bipartisan bill in an effort to lower drug prices, requiring drug manufacturers to justify price increases.
US and EU enter Mutual Recognition Agreement for drug manufacturing inspections europeanpharmaceuticalreview
July 17, 2019
The FDA and EMA have agreed to rely on each other’s assessment of pharmaceutical manufacturing sites to reduce duplicative work.
US judge blocks HHS rule to disclose drug prices in TV ads pharmaceutical-technology
July 10, 2019
US District Judge Amit Mehta has blocked a Department of Health and Human Services (HHS) rule that would have mandated drug manufacturers to disclose the list prices of their medication in television advertisements.
Teva Launches 1% Sodium Hyaluronate in US americanpharmaceuticalreview
July 03, 2019
Teva has announced the launch of 1% Sodium Hyaluronate. The product received approval from the Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA).
US$150 million invested to expand US pharmaceutical distribution network europeanpharmaceuticalreview
June 24, 2019
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
CDC: U.S. Measles Cases Reach 1,044 drugs
June 18, 2019
CDC: U.S. Measles Cases Reach 1,044.
Merck’s Keytruda secures expanded indications in US pharmaceutical-technology
June 14, 2019
The US Food and Drug Administration (FDA) has approved two indications for Merck’s Keytruda, expanding its application to the oncology market.
More countries added to the EU-US mutual recognition agreement drugs
June 14, 2019
Luxembourg and the Netherlands have been included in the mutual recognition agreement between the EU and the FDA in the US.
FDA dermatology advisors found to accept payments after drug approvals europeanpharmaceuticalreview
June 14, 2019
A study has shown that the majority of dermatology advisors to the FDA took payments subsequent to drug approvals.
Three more US states announce lawsuits against Purdue europeanpharmaceuticalreview
June 11, 2019
A total of 48 US states are now suing Purdue Pharma, claiming they falsely marketed their opioid drug.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page